NCT05859334 2026-03-19
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
7 trialsNCT06906562 2026-02-17
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
NCT05473507 2025-10-09
A Study of Observation and Follow-up in People With Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT04188912 2025-10-02
CATCH
Fred Hutchinson Cancer Center
Completed
NCT06321003 2025-05-23
SYMILIS OCT
University of Palermo
Recruiting
NCT06014697 2025-04-04
OCT and Invasion in Cutaneous Skin Lesions
Maastricht University Medical Center
Completed
NCT03711890 2025-03-30
Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Suspended